A real-life study of elexacaftor-tezacaftor-ivacaftor therapy in people with cystic fibrosis in Brazil L.Z. Salomão, R.A. Athanazio, S.Z. Rached, M. Lopes-Pacheco, M. Camargo

Efficacy of elexacaftor-tezacaftor-ivacaftor in portuguese adolescents and adults with cystic fibrosis carrying non-F508del variants M.O. Pinto, A.S. Santos, S. Castanhinha

Changes in exercise endurance and inspiratory capacity after lumacaftor/ivacaftor therapy in cystic fibrosis D. Savi, A. Gramegna, M. Vicenzi, M. Di Paolo, B. Messore, P. Palange, F. Blasi